Cefixime + Ofloxacin in pharma Himachal Pradesh

Cefixime + Ofloxacin Drop in PCD pharma franchise in Kohima

Cefixime + Ofloxacin in top pharma company in Kanpur

Cefixime + Ofloxacin in pcd pharma supplier in Rourkela

Cefixime + Ofloxacin in phama franchise company in India
Cefixime + Ofloxacin in phama distributor in Bharatpur

Home/Products /cefixime-50mg-ofloxacin-50mg-dry-syrup

Cefzlan O Dry Syrup

Composition : Cefixime (50mg) + Ofloxacin (50mg)

Dosage Form : Dry Syrup

Packaging Type : Vial + Water

Packaging : 30 ml

Price : ₹120/-

Cefzlan O Dry Syrup is a pediatric formulation that combines two effective antibiotics: cefixime (50 mg) and ofloxacin (50 mg). This unique combination targets a broad spectrum of bacterial infections, making it suitable for children suffering from conditions such as otitis media, respiratory tract infections, and urinary tract infections. The syrup is easy to administer and is formulated to be palatable for young patients, ensuring adherence to treatment.

Cefixime, a cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. Ofloxacin, a fluoroquinolone, disrupts bacterial DNA replication and repair, enhancing the overall antimicrobial effect of the formulation. Together, these agents provide a synergistic approach to treating infections, helping to reduce recovery time and prevent complications associated with untreated bacterial infections.

When using Cefzlan O, it is crucial to follow the prescribed dosage carefully. The syrup should be well-shaken before use to ensure an even distribution of the active ingredients. Treatment duration will depend on the type and severity of the infection, and it is important to complete the full course as advised by a healthcare professional to avoid resistance development.

Read More

About the Product

Cefzlan O Dry Syrup is a pediatric formulation that combines two effective antibiotics: cefixime (50 mg) and ofloxacin (50 mg). This unique combination targets a broad spectrum of bacterial infections, making it suitable for children suffering from conditions such as otitis media, respiratory tract infections, and urinary tract infections. The syrup is easy to administer and is formulated to be palatable for young patients, ensuring adherence to treatment.

Cefixime, a cephalosporin antibiotic, works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. Ofloxacin, a fluoroquinolone, disrupts bacterial DNA replication and repair, enhancing the overall antimicrobial effect of the formulation. Together, these agents provide a synergistic approach to treating infections, helping to reduce recovery time and prevent complications associated with untreated bacterial infections.

When using Cefzlan O, it is crucial to follow the prescribed dosage carefully. The syrup should be well-shaken before use to ensure an even distribution of the active ingredients. Treatment duration will depend on the type and severity of the infection, and it is important to complete the full course as advised by a healthcare professional to avoid resistance development.

Common side effects may include gastrointestinal disturbances, allergic reactions, and alterations in liver function tests.

Cefzlan O is indicated for the treatment of bacterial infections in children, including respiratory, urinary tract, and ear infections.

Always consult a healthcare provider before use, especially in cases of known allergies to antibiotics or pre-existing health conditions. Use with caution in patients with a history of tendon disorders or seizures. Cefzlan O Dry Syrup not only offers effective infection management but also enhances patient compliance through its child-friendly formulation. Always ensure that this medication is taken under proper medical guidance to maximize its benefits while minimizing potential risks.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation